A Small-Diameter Artificial Vascular Graft: Biocompatibility Evaluation and Regulatory Mechanisms of Vascular Remodeling at the Cellular and Molecular Levels

The increasing prevalence of cardiovascular diseases highlights the urgent demand for small-diameter artificial vascular grafts (SD-AVGs). However, the clinical application of current SD-AVGs is limited by complications such as thrombosis and proliferative stenosis. We first designed and fabricated a triple-layered SD-AVG (TL-SD-AVG) composed of polycarbonate polyurethane and polyethylene terephthalate using electrospinning and mixed weaving techniques. Then, we characterized its mechanical properties through standard mechanical testing. Cytotoxicity, cell adhesion assay hemolysis, and blood clotting assays were subsequently performed to preliminarily evaluate its cytocompatibility and hemocompatibility in vitro. Next, we assessed the TL-SD-AVG's tissue compatibility and biosafety using a porcine carotid artery replacement model. Finally, we employed both bulk RNA sequencing (RNA-seq) and single-nucleus RNA sequencing (snRNA-seq) to investigate the cellular and molecular mechanisms involved in vascular remodeling. Our results showed that the TL-SD-AVG exhibited adequate mechanical strength, low cytotoxicity, and a hemolysis rate below 5%, and its anticoagulant performance was better than the expanded polytetrafluoroethylene control graft. In vivo, the grafts maintained structural integrity and patency over a 4-week period, with no thrombus formation or pathological stenosis. Histopathological analyses revealed endothelial coverage of 34.66 ± 4.47% at 1 week, increasing to 72.14 ± 4.01% by 4 weeks. RNA-seq and snRNA-seq identified six key cell types involved in vascular regeneration, with no significant aberrations in pathways related to vascular remodeling. Both in vitro and in vivo experiments demonstrated that TL-SD-AVG had low cytotoxicity, good hemocompatibility, favorable histocompatibility, and overall biosafety. Moreover, it supported effective vascular remodeling, providing a robust theoretical and experimental foundation for its future clinical translation.

Authors

Institutions

Publication Details

Journal
ACS Applied Bio Materials
Published
2025-09-02
DOI
https://doi.org/10.1021/acsabm.5c00942
Citations
1
Primary Topic
Electrospun Nanofibers in Biomedical Applications
Type
article
Field-Weighted Citation Impact
0.60
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Small-Diameter Artificial Vascular Graft: Biocompatibility Evaluation and Regulatory Mechanisms of Vascular Remodeling at the Cellular and Molecular Levels

J. H. Fan, Matthew Yung, Chen‐Yang Shen, Gang Tian et al.
1 citations
ACS Applied Bio Materials
Electrospun Nanofibers in Biomedical Applications
0.60
article

A Small-Diameter Artificial Vascular Graft: Biocompatibility Evaluation and Regulatory Mechanisms of Vascular Remodeling at the Cellular and Molecular Levels

J. H. Fan, Matthew Yung, Chen‐Yang Shen, Gang Tian, Jiafei Luo, Zhenhao Zhang, Yunhui Lv, Jiafei Li, Peihe Wang, Xiaodong Hao, Xuemin Wang, Qi Zhang, Peng Peng, Jinyan Zhu, Shuo Wang, Xue Zhang, Ting Pan, Yongchun Cui
article en
1 citations

Abstract

The increasing prevalence of cardiovascular diseases highlights the urgent demand for small-diameter artificial vascular grafts (SD-AVGs). However, the clinical application of current SD-AVGs is limited by complications such as thrombosis and proliferative stenosis. We first designed and fabricated a triple-layered SD-AVG (TL-SD-AVG) composed of polycarbonate polyurethane and polyethylene terephthalate using electrospinning and mixed weaving techniques. Then, we characterized its mechanical properties through standard mechanical testing. Cytotoxicity, cell adhesion assay hemolysis, and blood clotting assays were subsequently performed to preliminarily evaluate its cytocompatibility and hemocompatibility in vitro. Next, we assessed the TL-SD-AVG's tissue compatibility and biosafety using a porcine carotid artery replacement model. Finally, we employed both bulk RNA sequencing (RNA-seq) and single-nucleus RNA sequencing (snRNA-seq) to investigate the cellular and molecular mechanisms involved in vascular remodeling. Our results showed that the TL-SD-AVG exhibited adequate mechanical strength, low cytotoxicity, and a hemolysis rate below 5%, and its anticoagulant performance was better than the expanded polytetrafluoroethylene control graft. In vivo, the grafts maintained structural integrity and patency over a 4-week period, with no thrombus formation or pathological stenosis. Histopathological analyses revealed endothelial coverage of 34.66 ± 4.47% at 1 week, increasing to 72.14 ± 4.01% by 4 weeks. RNA-seq and snRNA-seq identified six key cell types involved in vascular regeneration, with no significant aberrations in pathways related to vascular remodeling. Both in vitro and in vivo experiments demonstrated that TL-SD-AVG had low cytotoxicity, good hemocompatibility, favorable histocompatibility, and overall biosafety. Moreover, it supported effective vascular remodeling, providing a robust theoretical and experimental foundation for its future clinical translation.

ACS Applied Bio MaterialsVol. 8(9)
Macau University of Science and Technology (MO), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking Union Medical College Hospital (CN), Fu Wai Hospital (CN)
Openalex Percentile: Top 30%
Electrospun Nanofibers in Biomedical Applications
0.60
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.